• Skip to main content
  • Skip to footer

PeDRA

Pediatric Dermatology Research Alliance

  • Pay 2021 Membership Dues
  • Our Membership
  • Login
MENUMENU
  • Contact
  • For Patients & Families
        • Patient Support
        • Patient Education
        • Find a Pediatric Dermatologist (from SPD)
        • Clinical Trials
        • Patient Advisory Committee
        • Learn more about PeDRA’s efforts to build capacity for patient engagement in pediatric dermatology research.

           

  • Education and Events
        • Virtual Education
        • PeDRA Podcasts
        • Mentorship Program
        • Early Career Support
        • 2021 PeDRA Annual Conference
        • Past PeDRA Conferences
        • Upcoming Events
        • Education and Events Archive
        • Save the Date!

          The 2021 PeDRA Annual Conference will take place October 14-16, 2021 in Bethesda, MD.

           

  • Research
        • Grants & Awards
        • Studies
        • Focused Study Groups
        • Publications
        • Clinical Trials
        • Research Fellowships

          Applications are now being accepted to the 2021 PeDRA Research Fellowships program. Deadline to apply is Thursday, April 1, 2021.

  • About
        • Mission & Vision
        • Leadership & Staff
        • Annual Reports
        • News Archive
        • Our Supporters
        • Our Membership
        • Our Committees
        • Getting to Know You
        • PeDRA is an independent 501(c)(3) nonprofit organization driven by the mission to create, inspire, and sustain research to prevent, treat, and cure childhood skin disease.

  • Member Login

Exploring the Cutaneous Microbiome in Premature Neonates: A Pilot Study

November 10, 2019 By Mike Siegel

Principal Investigator:

Jennifer Schoch, MD
University of Florida

Overview:

The study sought to characterize the cutaneous microbiome in a cohort of premature infants, and explore the impact of early postnatal antibiotic exposure on the cutaneous microbiome. Bacterial colonization of both the infant gut and skin are likely critical in immune system development, though little is known about the parallel assembly of the microbiome across sites. This study built on the previous work on the impact of antibiotics on the intestinal microbiome, metabolome, and inflammatory responses in premature infants. The addition of cutaneous microbiome sampling to this existing cohort allowed for comparison between the development of the microbiome in both the skin and gut within the same subject. It also allowed the exploration the impact of antibiotic exposure on cutaneous microbial diversity and adverse outcomes including sepsis. Finally, in the event of adverse outcomes, cultured pathogenic organisms will be compared to microbial profiles of the skin and intestine to explore which site was likely breached. We hypothesized that antibiotic exposure was associated with a loss of microbial diversity across both the cutaneous and intestinal microbiome, and that these effects extend beyond the duration of the antibiotic exposure. We also suspected that the altered microbial ecology would be associated with a higher incidence of adverse outcomes, including late onset sepsis (LOS), which can be associated with a breach in the intestinal, mucosal, or cutaneous barrier.

Status:

This study was funded as a 2017 PeDRA Pilot Grant and is now complete. Final results were presented at the 2019 Annual Meeting of the Society for Pediatric Dermatology.

Filed Under: Completed Studies

Footer

  • Our Membership
  • For Patients
  • For Researchers
  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
Sign up to receive emails from PeDRA
Join PeDRA
Donate

Copyright © 2021 · Pediatric Dermatology Research Alliance (PeDRA) · All Rights Reserved. · Privacy Policy